US Stock MarketDetailed Quotes
ANNX Annexon
- 6.970
- -0.260-3.60%
Close Nov 11 16:00 ET
- 6.970
- 0.0000.00%
Post 20:01 ET
736.41MMarket Cap-5760P/E (TTM)
7.290High6.960Low755.90KVolume7.260Open7.230Pre Close5.36MTurnover1.10%Turnover RatioLossP/E (Static)105.65MShares8.40052wk High2.04P/B479.78MFloat Cap2.27052wk Low--Dividend TTM68.84MShs Float38.010Historical High--Div YieldTTM4.56%Amplitude1.570Historical Low7.087Avg Price1Lot Size
About Annexon Company
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Company Profile
SymbolANNX
Company NameAnnexon
Listing DateJul 24, 2020
Issue Price17.00
Founded2011
CEOMr. Douglas Love, Esq.
MarketNASDAQ
Employees71
Fiscal Year Ends12-31
Address1400 Sierra Point Parkway,Building C,Suite 200
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-822-5500
Websitehttp://www.annexonbio.com
Company Executives
- Name
- Position
- Salary
- Douglas Love, Esq.
- President, Chief Executive Officer and Director
- 2.45M
- Ted Yednock,PhD
- Executive Vice President and Chief Innovation Officer
- 1.14M
- Michael Overdorf
- Executive Vice President and Chief Business Officer
- --
- Dr. Dean Richard Artis, PhD
- Executive Vice President and Chief Scientific Officer
- 1.83M
- Jennifer Lew
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Jamie Dananberg, M.D.
- Executive Vice President and Chief Medical Officer
- --
- Thomas G. Wiggans
- Chairman of the Board
- 132.43K
- Dr. William H. Carson, M.D.
- Independent Director
- 103.43K
- Jung E. Choi
- Independent Director
- 100.93K
- William D. Waddill
- Independent Director
- 103.43K
- Muneer A. Satter
- Independent Director
- 103.93K
- Bettina M. Cockroft
- Independent Director
- 100.93K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data